Loading…

Edwards Lifesciences agreed to pay 15 million euros (about $16.3 million) for a 9.21% equity stake in France's Affluent Medical, including an exclusive option to buy its mitral ring subsidiary and a global license for biomimetic mitral valve replacement technology.
“In a separate deal announced Friday, Edwards agreed to pay 15 million euros (about $16.3 million) for a stake in France’s Affluent Medical and access to its technologies.”medtechdive.com
Summarized from public sources; check the original articles before acting on it.